WASHINGTON -- Medicare recipients will get a premium reduction — but not until next year — reflecting an overestimate in costs of covering an expensive and controversial new Alzheimer's drug.
A case asking whether insurers and pharmacy benefit managers face ERISA liability when negotiating drug prices doesn’t merit US Supreme Court review, according to a federal government brief advising the justices to skip a case involving Anthem Inc. and Express Scripts Inc.
Since 2021, in an effort to encourage greater transparency in the prescription drug industry, there has been a national trend toward increased state licensing and regulation of Pharmacy Benefit Managers (PBMs). PBMs are paid third-party administrators of prescription drug coverage for insurers and employers.
People who buy their own health insurance in Maryland may find again that they must pay more next year, likely due to costs from the coronavirus pandemic. The three carriers offering policies on Maryland’s health exchange or directly to consumers under the Affordable Care Act requested rate increases from state insurance regulators averaging 11%.
Anthem Inc.'s chief information officer says he is working with Alphabet Inc.'s Google Cloud to create a synthetic data platform that will let the health insurance company better detect fraud and offer personalized care to its members. Anil Bhatt said the plan is to use algorithms and statistical models to generate approximately 1.5 to 2 petabytes of synthetic data, including artificially generated data sets of medical histories, healthcare claims and other key medical data, created in partnership with Google Cloud.
